Correlation Between Cisco Systems and Nabriva Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Cisco Systems and Nabriva Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cisco Systems and Nabriva Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cisco Systems and Nabriva Therapeutics AG, you can compare the effects of market volatilities on Cisco Systems and Nabriva Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cisco Systems with a short position of Nabriva Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cisco Systems and Nabriva Therapeutics.

Diversification Opportunities for Cisco Systems and Nabriva Therapeutics

-0.39
  Correlation Coefficient

Very good diversification

The 3 months correlation between Cisco and Nabriva is -0.39. Overlapping area represents the amount of risk that can be diversified away by holding Cisco Systems and Nabriva Therapeutics AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nabriva Therapeutics and Cisco Systems is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cisco Systems are associated (or correlated) with Nabriva Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nabriva Therapeutics has no effect on the direction of Cisco Systems i.e., Cisco Systems and Nabriva Therapeutics go up and down completely randomly.

Pair Corralation between Cisco Systems and Nabriva Therapeutics

If you would invest  5,477  in Cisco Systems on September 1, 2024 and sell it today you would earn a total of  444.00  from holding Cisco Systems or generate 8.11% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy4.76%
ValuesDaily Returns

Cisco Systems  vs.  Nabriva Therapeutics AG

 Performance 
       Timeline  
Cisco Systems 

Risk-Adjusted Performance

21 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Cisco Systems are ranked lower than 21 (%) of all global equities and portfolios over the last 90 days. In spite of very conflicting fundamental indicators, Cisco Systems displayed solid returns over the last few months and may actually be approaching a breakup point.
Nabriva Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Nabriva Therapeutics AG has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, Nabriva Therapeutics is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Cisco Systems and Nabriva Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Cisco Systems and Nabriva Therapeutics

The main advantage of trading using opposite Cisco Systems and Nabriva Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cisco Systems position performs unexpectedly, Nabriva Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nabriva Therapeutics will offset losses from the drop in Nabriva Therapeutics' long position.
The idea behind Cisco Systems and Nabriva Therapeutics AG pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..

Other Complementary Tools

My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.